Primed Infusion with Delayed Equilibrium of Gd.DTPA for Enhanced Imaging of Small Pulmonary Metastases

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kalber, Tammy L ^a,b   Campbell Washburn, Adrienne E ^a   Siow, Bernard M ^a   Sage, Elizabeth ^b   Price, Anthony N ^a   Ordidge, Katherine L ^a,b   Walker Samuel, Simon ^a   Janes, Sam M ^b   Lythgoe, Mark F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG INFUSION; DRUG MEGADOSE; GATED IMAGING; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE DRUG DOSE; TUMOR SEEDING; TUMOR VOLUME;

ANIMALS; CHELATING AGENTS; CONTRAST MEDIA; GADOLINIUM; GADOLINIUM DTPA; HEK293 CELLS; HUMANS; INFUSIONS, PARENTERAL; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM METASTASIS; TIME FACTORS; TUMOR BURDEN;

EID: 84873190540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054903     Document Type: Article

References (47)

1. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, et al. (1984) Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 86: 44-53.
2. Frost JK, Ball WC Jr, Levin ML, Tockman MS, Baker RR, et al. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 130: 549-554.
3. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, et al. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 130: 561-565.
4. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, et al. (2005) Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 47: 9-15.
5. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395-409.
6. Spiro SG, Navani N, (2012) Screening for lung cancer: is this the way forward? Respirology 17: 237-246.
7. Kennel SJ, Davis IA, Branning J, Pan H, Kabalka GW, et al. (2000) High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology. Med Phys 27: 1101-1107.
8. Patz EF, Jr., Black WC, Goodman PC (2001) CT screening for lung cancer: not ready for routine practice. Radiology 221: 587-591; discussion 598-589.
9. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, et al. (1990) Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31: 1927-1932.
10. Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, et al. (1992) Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 184: 441-444.
11. Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, et al. (2005) Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol 23: 8362-8370.
12. Song JW, Oh YM, Shim TS, Kim WS, Ryu JS, et al. (2009) Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Lung Cancer 65: 333-338.
13. Gambhir SS, (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2: 683-693.
14. Gould MK, Fletcher J, Iannettoni MD, Lynch WR, Midthun DE, et al. (2007) Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 108S-130S.
15. Weissleder R, (2002) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2: 11-18.
16. Runge VM, Wood ML, (1988) Fast imaging and other motion artifact reduction schemes: a pictorial overview. Magn Reson Imaging 6: 595-607.
17. Hatabu H, Alsop DC, Listerud J, Bonnet M, Gefter WB, (1999) T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 29: 245-252.
18. Semelka RC, Helmberger TK, (2001) Contrast agents for MR imaging of the liver. Radiology 218: 27-38.
19. Padhani AR, Husband JE, (2001) Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56: 607-620.
20. Fukumura D, Yuan F, Monsky WL, Chen Y, Jain RK, (1997) Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151: 679-688.
21. Iyer AK, Khaled G, Fang J, Maeda H, (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11: 812-818.
22. Padhani AR, (1999) Dynamic contrast-enhanced MRI studies in human tumours. Br J Radiol 72: 427-431.
23. Tofts PS, Berkowitz BA, (1994) Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn Reson Imaging 12: 81-91.
24. Parker GJM, Clark D, Watson Y, Buckley DL, Berrisford C, et al. (2003) T1-Weighted DCE-MRI Apllied to Lung Tumours: Pre-Processing and Modelling. Proceedings of the 11th ISMRM Toronto: 1255.
25. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, et al. (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122: 138-144.
26. Campbell AE, Price AN, Ellmerich S, Simons P, Al-Shawi R, et al. (2011) Equilibrium contrast CMR for the detection of amyloidosis in mice. JCMR 13(S1): O60.
27. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D, (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
28. Price AN, Cheung KK, Lim SY, Yellon DM, Hausenloy DJ, et al. (2011) Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T. J Cardiovasc Magn Reson 13: 44.
29. Tidwell VK, Garbow JR, Krupnick AS, Engelbach JA, Nehorai A, (2012) Quantitative analysis of tumor burden in mouse lung via MRI. Magn Reson Med 67: 572-579.
30. Aguilar S, Scotton CJ, McNulty K, Nye E, Stamp G, et al. (2009) Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 4: e8013.
31. Vaupel P, Kallinowski F, Okunieff P, (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465.
32. Fleming JB, Brekken RA, (2003) Functional imaging of angiogenesis in an orthotopic model of pancreatic cancer. J Cell Biochem 90: 492-501.
33. Bergers G, Benjamin LE, (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
34. Jain RK, (2005) Antiangiogenic therapy for cancer: current and emerging concepts. Oncology (Williston Park) 19: 7-16.
35. Garbow JR, Zhang Z, You M, (2004) Detection of primary lung tumors in rodents by magnetic resonance imaging. Cancer Res 64: 2740-2742.
36. Hatabu H, Chen Q, Stock KW, Gefter WB, Itoh H, (1999) Fast magnetic resonance imaging of the lung. Eur J Radiol 29: 114-132.
37. Togao O, Tsuji R, Ohno Y, Dimitrov I, Takahashi M, (2010) Ultrashort echo time (UTE) MRI of the lung: assessment of tissue density in the lung parenchyma. Magn Reson Med 64: 1491-1498.
38. Takahashi M, Togao O, Obara M, van Cauteren M, Ohno Y, et al. (2010) Ultra-short echo time (UTE) MR imaging of the lung: comparison between normal and emphysematous lungs in mutant mice. J Magn Reson Imaging 32: 326-333.
39. Kokuryo D, Kumamoto E, Takao Y, Fujii S, Kaihara T, et al. (2012) Evaluation of a vessel-tracking-based technique for dynamic targeting in human liver. Magn Reson Med 67: 156-163.
40. Rinck PA, Petersen SB, Lauterbur PC, (1984) [NMR imaging of fluorine-containing substances. 19-Fluorine ventilation and perfusion studies]. Rofo 140: 239-243.
41. Edelman RR, Hatabu H, Tadamura E, Li W, Prasad PV, (1996) Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med 2: 1236-1239.
42. Albert MS, Cates GD, Driehuys B, Happer W, Saam B, et al. (1994) Biological magnetic resonance imaging using laser-polarized 129Xe. Nature 370: 199-201.
43. Saam BT, Yablonskiy DA, Kodibagkar VD, Leawoods JC, Gierada DS, et al. (2000) MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med 44: 174-179.
44. Salerno M, Altes TA, Mugler JP 3rd, Nakatsu M, Hatabu H, et al (2001) Hyperpolarized noble gas MR imaging of the lung: potential clinical applications. Eur J Radiol 40: 33-44.
45. Driehuys B, Hedlund LW, (2007) Imaging techniques for small animal models of pulmonary disease: MR microscopy. Toxicol Pathol 35: 49-58.
46. Branca RT, Cleveland ZI, Fubara B, Kumar CS, Maronpot RR, et al. (2010) Molecular MRI for sensitive and specific detection of lung metastases. Proc Natl Acad Sci U S A 107: 3693-3697.
47. Fan X, Medved M, River JN, Zamora M, Corot C, et al. (2004) New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn Reson Med 51: 487-494.